# Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization

> **NCT05347069** · PHASE4 · RECRUITING · sponsor: **Takeshi Morimoto** · enrollment: 2890 (estimated)

## Conditions studied

- Stable Angina Pectoris
- Coronary Artery Disease
- Ischemic Heart Disease

## Interventions

- **DRUG:** Aspirin
- **DRUG:** No aspirin

## Key facts

- **NCT ID:** NCT05347069
- **Lead sponsor:** Takeshi Morimoto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-14
- **Primary completion:** 2030-03
- **Final completion:** 2030-12
- **Target enrollment:** 2890 (ESTIMATED)
- **Last updated:** 2025-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05347069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05347069, "Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05347069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*